Wer ist noch investiert? Wer weiß genau, wieviele Aktien die aktuell am Markt haben. Bei OTCBB steht was von 10 Mio Shares, an einer anderen Stelle steht wieder was von 20 Mio Shares outstanding?
OTC ist immer so eine Sache, aber so lange die nicht mit neuen Aktien verwässern, kann man sich ja noch Hoffnung machen. Ich bin nach dem Split reingegangen und überlege noch, einmal nachzukaufen? Letzten News unten. Schwer einzuschätzen, da OTC oftmals nur Betrügerbuden sind?
Börse NASDAQ OTC BBS
Aktuell 0,027 USD
Zeit 21.06.04 21:57
Diff. Vortag +8,00 %
Tages-Vol. 4.852,45
Geh. Stück 163.580
Geld 0,025
Brief 0,03
Zeit 21.06.04 21:49
Spread 16,667%
Geld Stk. 5.000
Brief Stk. --
Schluss
Vortag 0,025
Eröffnung 0,027
Hoch 0,036
Tief 0,022
52W Hoch --
52W Tief --
Split --
QT 5, Inc. Retains Equitilink LLC for Investor Relations
WESTLAKE VILLAGE, Calif., June 2, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI), manufacturer, distributor and marketer of biomedical products, today announced that it has retained Equitilink LLC of La Jolla, Calif. as its investor relations firm.
QT 5, Inc. President, Steven H. Reder said, "Our Company's corporate development and growth opportunities are at the point where it is appropriate to retain a sophisticated investor relations firm. We are impressed with Equitilink's broad and proactive relationship with investors who invest in micro cap stocks, and with the extensive and diverse experience of its executives. We believe it is the right firm to advise and assist QT 5, Inc. in our financial communications."
"We believe that QT 5, Inc. has the business plan and the management to succeed at introducing and marketing their full line of diagnostic and first-aid products. We look forward to advising and assisting the company on its financial communications and shareholder relations," said Jim Mahoney, Managing Director of Equitilink LLC. Investors interested in listening to Equitilink's plan for increasing shareholder value for QT 5, Inc. are encouraged to call Equitilink's Investor Service Representatives toll-free at 1-877-788-1940.
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: (www.qt5inc.com).
Safe Harbor
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
CONTACTS: QT 5, Inc.
Steve Reder
President
(818) 338-1510
sreder@qt5inc.com
Equitilink LLC
Investor Relations
(877) 788-1940 (toll-free)
OTC ist immer so eine Sache, aber so lange die nicht mit neuen Aktien verwässern, kann man sich ja noch Hoffnung machen. Ich bin nach dem Split reingegangen und überlege noch, einmal nachzukaufen? Letzten News unten. Schwer einzuschätzen, da OTC oftmals nur Betrügerbuden sind?
Börse NASDAQ OTC BBS
Aktuell 0,027 USD
Zeit 21.06.04 21:57
Diff. Vortag +8,00 %
Tages-Vol. 4.852,45
Geh. Stück 163.580
Geld 0,025
Brief 0,03
Zeit 21.06.04 21:49
Spread 16,667%
Geld Stk. 5.000
Brief Stk. --
Schluss
Vortag 0,025
Eröffnung 0,027
Hoch 0,036
Tief 0,022
52W Hoch --
52W Tief --
Split --
QT 5, Inc. Retains Equitilink LLC for Investor Relations
WESTLAKE VILLAGE, Calif., June 2, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI), manufacturer, distributor and marketer of biomedical products, today announced that it has retained Equitilink LLC of La Jolla, Calif. as its investor relations firm.
QT 5, Inc. President, Steven H. Reder said, "Our Company's corporate development and growth opportunities are at the point where it is appropriate to retain a sophisticated investor relations firm. We are impressed with Equitilink's broad and proactive relationship with investors who invest in micro cap stocks, and with the extensive and diverse experience of its executives. We believe it is the right firm to advise and assist QT 5, Inc. in our financial communications."
"We believe that QT 5, Inc. has the business plan and the management to succeed at introducing and marketing their full line of diagnostic and first-aid products. We look forward to advising and assisting the company on its financial communications and shareholder relations," said Jim Mahoney, Managing Director of Equitilink LLC. Investors interested in listening to Equitilink's plan for increasing shareholder value for QT 5, Inc. are encouraged to call Equitilink's Investor Service Representatives toll-free at 1-877-788-1940.
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: (www.qt5inc.com).
Safe Harbor
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
CONTACTS: QT 5, Inc.
Steve Reder
President
(818) 338-1510
sreder@qt5inc.com
Equitilink LLC
Investor Relations
(877) 788-1940 (toll-free)